Paper357653
Homeostasis of effector systems which can also be recruited for immunologic reactions.
Austen KF. J Immunol, 1978. Cited by 60 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Homeostasis of effector systems which can also be recruited for immunologic reactions. Papers, record 357653. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/357653
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Homeostasis | Major topic |
| Immunity | Major topic |
| Anaphylaxis | |
| Animals | |
| Antigen-Antibody Reactions | |
| Chemotaxis, Leukocyte | |
| Complement Pathway, Alternative | |
| Eosinophils | |
| Guinea Pigs | |
| Humans | |
| Hypersensitivity, Immediate | |
| Mast Cells | |
| Oligopeptides | |
| Properdin |
Source PubMed
Cited by23
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 60 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38,549,811 | Eosinophil granulocytes in chronic inflammatory respiratory diseases and CRSwNP: Function, immunological basis, and clinical significance. | Allergol Select | 2024 | https://conductscience.org/library/papers/38549811 | PubMed |
| 33,671,475 | Heterogeneity of Intestinal Tissue Eosinophils: Potential Considerations for Next-Generation Eosinophil-Targeting Strategies. | Cells | 2021 | https://conductscience.org/library/papers/33671475 | PubMed |
| 24,795,292 | Changing roles of eosinophils in health and disease. | Ann Allergy Asthma Immunol | 2014 | https://conductscience.org/library/papers/24795292 | PubMed |
| 22,936,660 | The expanding role(s) of eosinophils in health and disease. | Blood | 2012 | https://conductscience.org/library/papers/22936660 | PubMed |
| 20,447,076 | Eosinophils in health and disease: the LIAR hypothesis. | Clin Exp Allergy | 2010 | https://conductscience.org/library/papers/20447076 | PubMed |
| 11,122,232 | Pathogenic roles of eosinophils in guinea-pig contact sensitivity: regulation of dermal eosinophilia with remotely administered IL-5. | Clin Exp Immunol | 2000 | https://conductscience.org/library/papers/11122232 | PubMed |
| 7,430,350 | Receptor-directed inhibition of chemotactic factor-induced neutrophil hyperactivity by pyrazolon derivatives. Definition of a chemotactic peptide antagonist. | J Clin Invest | 1980 | https://conductscience.org/library/papers/7430350 | PubMed |
| 7,044,460 | Eighth Gaddum Memorial Lecture. University of London Institute of Education, December 1980. Biological importance of prostacyclin. | Br J Pharmacol | 1982 | https://conductscience.org/library/papers/7044460 | PubMed |
| 6,854,212 | Activation of basophil and mast cell histamine release by eosinophil granule major basic protein. | J Exp Med | 1983 | https://conductscience.org/library/papers/6854212 | PubMed |
| 6,824,817 | An in vivo model for measuring antigen-induced SRS-A-mediated bronchoconstriction and plasma SRS-A levels in the guinea-pig. | Br J Pharmacol | 1983 | https://conductscience.org/library/papers/6824817 | PubMed |
| 6,821,372 | Factor D of the alternative pathway of human complement. Purification, alignment and N-terminal amino acid sequences of the major cyanogen bromide fragments, and localization of the serine residue at the active site. | Biochem J | 1980 | https://conductscience.org/library/papers/6821372 | PubMed |
| 6,805,265 | Eosinophil diamine oxidase activity in acute inflammation in humans. | Agents Actions | 1982 | https://conductscience.org/library/papers/6805265 | PubMed |
| 6,780,451 | Importance of the integrity of the inter-heavy-chain disulphide bond of rabbit IgG in the activation of the alternative pathway of human complement by the F(ab')2 region of rabbit IgG antibody in immune aggregates. | Immunology | 1981 | https://conductscience.org/library/papers/6780451 | PubMed |
| 6,704,285 | Does the addition of ketotifen to non-steroidal anti-inflammatory drugs confer any additional benefit in rheumatoid arthritis? | Br J Clin Pharmacol | 1984 | https://conductscience.org/library/papers/6704285 | PubMed |
| 6,696,523 | Mast cells at sites of cartilage erosion in the rheumatoid joint. | Ann Rheum Dis | 1984 | https://conductscience.org/library/papers/6696523 | PubMed |
| 6,376,103 | Control of cellular influx in lung and its role in pulmonary toxicology. | Environ Health Perspect | 1984 | https://conductscience.org/library/papers/6376103 | PubMed |
| 6,372,708 | High histamine level in the blister fluid of bullous pemphigoid. | Arch Dermatol Res | 1984 | https://conductscience.org/library/papers/6372708 | PubMed |
| 6,103,542 | Leukotriene D: a slow reacting substance from rat basophilic leukemia cells. | Proc Natl Acad Sci U S A | 1980 | https://conductscience.org/library/papers/6103542 | PubMed |
| 6,091,141 | Leukotrienes in the rat central nervous system. | Proc Natl Acad Sci U S A | 1984 | https://conductscience.org/library/papers/6091141 | PubMed |
| 4,029,033 | Leukotrienes in disease. Implications for drug development. | Drugs | 1985 | https://conductscience.org/library/papers/4029033 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/357653
GET https://conductscience.org/api/papers/v1/357653/cited_by?page=2